Highest-materiality recent filing
Global Innovative Platforms shareholder update lacks specific details in filing
Company issued shareholder update letter on June 15, 2026, but exhibit text is incomplete.
Board size increased from one to four directors effective April 1, 2026.
Global Innovative Platforms posts updated investor presentation on website
Presentation posted March 31, 2026, available at www.vetbreath.com under Investor Relations.
Preliminary analysis of breath samples using VOCAM Plus identified a consistent VOC profile distinguishing heartworm-infected from uninfected dogs.
Inks diagnostic supply deal with animal health co; switches auditor to CNGSN
Agreement to supply VOCAM Plus units and support for evaluation of canine heartworm detection using breathomics.
Global Innovative Platforms posts updated investor presentation on its website
Company filed Form 8-K on September 26, 2025 for Regulation FD disclosure.
Global Innovative Platforms posts updated investor presentation; no material new details disclosed
Updated investor presentation made available on company website on June 23, 2025.
Investor presentation originally posted on company website on December 20, 2023; furnished as exhibit to 8-K dated February 7, 2024.
Global Innovative Platforms issues 24.5M shares at $0.0001/share to raise $2,453
Sold 24,531,027 shares of common stock at $0.0001 per share on October 23, 2023.
License covers exclusive global rights to patents and know-how for animal testing and related commercial applications.
Global Innovative Platforms appoints Andrew Brown CEO, CFO, Secretary; Matthew Veal resigns
Matthew Veal resigned as director and executive officer on July 26, 2023.
Global Innovative Platforms appoints Matthew Veal as CEO and CFO
Matthew Veal appointed CEO, CFO, and Secretary effective January 4, 2022.
Director and executive officer John Shepard resigns from Global Innovative Platforms
John Shepard resigned as executive officer and director on November 3, 2021.
Company changes name to Global Innovative Platforms Inc., new symbol GIPL effective Sept 13
Certificate of Amendment filed May 10, 2021, effective May 20, 2021, to change name from Canning Street Corporation to Global Innovative Platforms Inc.
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On July 26, 2023, Matthew Veal resigned as a director and executive officer of Global Innovation Platforms Inc. (the “Company”).
on July 26, 2023, Andrew Brown was appointed as a director and Chief Executive Officer, Chief Financial Officer and Secretary of the Company.
On January 4, 2022, Matthew Veal was engaged as the Company’s Chief Executive Officer, Chief Financial Officer and Secretary of Global Innovative Platforms Inc. (the “Company”).
On November 3, 2021, John Shepard resigned as an executive officer and director of Global Innovative Platforms Inc. (the "Company").
Max materiality 0.70 · Median 0.30 · Most common event other_material